Previous Close | 0.4600 |
Open | 0.4700 |
Bid | 0.4600 x N/A |
Ask | 0.4700 x N/A |
Day's Range | 0.4500 - 0.4700 |
52 Week Range | 0.3000 - 1.3300 |
Volume | |
Avg. Volume | 33,992 |
Market Cap | 45.9M |
Beta (5Y Monthly) | 1.60 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2300 |
Earnings Date | Oct 23, 2024 - Oct 28, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.08 |
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced the completion of patient enrollment in a pivotal study evaluating the use of its next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence ("AI") technology with optical coherence tomography ("OCT"), during breast-conserving surgeries ("BCS").
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the closing of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering").
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that it is undertaking a non-brokered private placement of up to 32,175,032 common shares in the capital of the Company ("Common Shares") at a price of $0.42 per Common Share, for aggregate gross proceeds of up to approximately $13.5 million (the "Offering"). All dollar figures are quoted in Canadian dollars.